Human CD & Other Cellular Antigens
Antibodies for multicolor flow cytometry, functional assays and immunohistochemistry
eBioscience human antibodies are available conjugated to a variety of fluorophores to enable multicolor flow cytometry, functional assays, and immunohistochemistry applications. Additional antibodies to other human antigens including novel cell surface molecules are in our pipeline.
| Antigen Name | Other Names | MW | Structure | Distribution | Function | eBioscience Clone |
|---|---|---|---|---|---|---|
| CD1a | T6 | 49kD | IgSF, MHC-like | cortical thymocytes, Langerhans cells, DC | antigen presentation, with beta2m | HI149 |
| CD1b | T6 | 45kD | IgSF, MHC-like | cortical thymocytes, Langerhans cells, DC | antigen presentation, with beta2m | eBioSN13 |
| CD1c | T6 | 43kD | IgSF, MHC-like | cortical thymocytes, Langerhans cells, DC, B subset | antigen presentation, with beta2m | |
| CD1d | 49kD | IgSF, MHC-like | intestinal epith, B subset, monolow, DC | antigen presentation, with beta2m | ||
| CD1e | 28kD | IgSF, MHC-like | DC | antigen presentation, with beta2m | ||
| CD2 | T11, LFA-2, SRBC-R | 50kD | IgSF | thymocytes, T, NK | CD58 ligand, adhesion, T cell activation | RPA-2.10 |
| CD2R | T11-3 | 50kD | IgSF | Tact | activation-dependent form of CD2 | |
| CD3 gamma, CD3 delta | T3 | IgSF | T, thymocyte subset | with TCR, TCR surface expression / signal transduction | ||
| CD3 epsilon | T3 | 20kD | IgSF | T, thymocyte subset | with TCR, TCR surface expression / signal transduction | OKT3 |
| UCHT1 | ||||||
| HIT3a | ||||||
| CD4 | T4 | 55kD | IgSF | thymocyte subset, T subset, mono, mac | MHC class II coreceptor, HIV receptor, T cell differentiation / activation | RPA-T4 |
| OKT4 | ||||||
| CD5 | T1, Tp67 | 67kD | Scavenger R SF | thymocytes, T, B subset, B-CLL | CD72 receptor, TCR or BCR signaling, T-B interaction | UCHT2 |
| CD6 | T12 | 100-130kD | Scavenger R SF | thymocytes, T, B subset | CD166 receptor, T cell differentiation / costimulation | |
| CD7 | 40kD | IgSF | hematopoietic progenitors, thymocytes, T, NK | T costimulation | CD7-6B7 | |
| CD8a | T8, Leu-2 | 32-34kD | IgSF | thymocyte subset, T subset, NK | MHC class I coreceptor, receptor for some mutated HIV-1, T cell differentiation / activation | RPA-T8 |
| HIT8a | ||||||
| OKT8 | ||||||
| CD8b | 30-32kD | IgSF | thymocyte subset, T subset | |||
| CD9 | p24, MRP-1 | 22-27kD | TM4SF | pre-B, eosinophils, basophils, platelets, Tact | cellular adhesion and migration | eBioSN4 (SN4 C3-3A2) |
| CD10 | CALLA, NEP, gp100 | 100kD | type II TM | B precursors, T precursors, neutrophils | zinc-binding metalloproteinase, B cell development | eBioCB-CALLA (CB-CALLA) |
| CD11a | LFA-1, integrin alphaL | 180kD | Integrin family | lymph, gran, mono, mac | CD11a / CD18 receptor for ICAM-1, -2,-3, intercellular adhesion, T costimulation | HI111 |
| CD11b | Mac-1, integrin alphaM | 170kD | Integrin family | myeloid cells, NK | binds CD54, ECM, iC3b | CBRM1/5 |
| ICRF44 | ||||||
| CD11c | p150, 95, CR4, integrin alphaX | 150kD | Integrin family | DC, myeloid cells, NK, B, T subset | binds CD54, fibrinogen and iC3b | 3.9 |
| CD12 | 90-120kD | mono, gran, platelets | ||||
| CD13 | Aminopeptidase N, APN | 150-170kD | type II TM | myeloid cells | zinc-binding metalloproteinase, antigen processing, receptor for corona virus strains | WM-15 |
| CD14 | LPS-R | 53-55kD | GPI-linked | mono, mac, Langerhans cells, granlow | receptor for LPS/LBP, LPS recognition | 61D3 |
| CD15 | Lewis-x, Lex | CHO | neutrophils, eosinophils, mono | adhesion | HI98 | |
| CD15s | Sialyl Lewis X | CHO | neutrophils, eosinophils, mono, memory helper T, Tact and B, NK, HEV | CD62L and CD62P ligand, adhesion | ||
| CD15u | Sulfated Lewis X | CHO | myeloid subset | adhesion | ||
| CD16a | FcgammaRIIIA | 50-65kD | IgSF | neutrophils, mac, NK | component of low affinity Fc receptor, phagocytosis and ADCC | eBioCB16 (CB16) |
| CD16b | FcgammaRIIIB | 48kD | IgSF | neutrophils | component of low affinity Fc receptor, phagocytosis and ADCC | |
| CD17 | neutrophils, mono, platelets | lactosyl ceramide | ||||
| CD18 | Integrin beta2 | 95kD | Integrin family | broad, all leukocytes | with CD11a, b & c, adhesion | CLB-LFA-1/1 |
| CD19 | B4 | 95kD | IgSF | B, FDC | complex with CD21 and CD81, BCR coreceptor, B cell activation / differentiation | HIB19 |
| CD20 | B1, Bp35 | 33-37kD | TM4SF | B, T subset | B cell activation | 2H7 |
| CD21 | C3DR, CR2, EBV-R | 145,110kD | CCRSF | B, FDC, T subset | complement C3d and EBV receptor, complex with CD19 and CD81, BCR coreceptor | BU32 |
| CD22 | BL-CAM, Siglec-2 | 150kD | IgSF, sialoadhesins | B | adhesion, B-mono, B-T interactions | eBio4KB128 |
| CD23 | FcepsilonRII | 45kD | C-type lectin | B, activated mac, eosinophils, FDC, platelets | CD19-CD21-CD81 receptor, IgE low affinity receptor, signal transduction | EBVCS2 |
| CD24 | BA-1 | 35-45kD | GPI-linked | thymocytes, erythrocytes, peripheral lymph, myeloid | binds P-selectin | eBioSN3 (SN3 A5-2H10) |
| CD25 | Tac, p55 | 55kD | type I TM | Tact, Bact, lymph progenitors | IL-2Ralpha, with IL-2Rbeta and gamma to form high affinity complex | BC96 |
| CD26 | DPP IV | 110kD | type II TM | thymocyte subset, Tact, soluble form | dipeptidyl peptidase, T costimulation, HIV entry | 2A6 |
| CD27 | T14 | 50-55kD | TNFRSF | medullary thymocytes, T, B subset, NK subset | CD70 receptor, T costimulation | O323 |
| LG.7F9 | ||||||
| CD28 | Tp44, T44 | 44kD | IgSF | most T, thymocytes, plasma cells | CD80, CD86 receptor, T costimulation | CD28.2 |
| CD28.6 | ||||||
| CD29 | Integrin beta1 | 130kD | Integrin family | lymph, mono, granlow, platelets, mast cells, fibroblasts, endoth | with CD49a (VLA-1) receptor for VCAM-1, MAdCAM-1 and ECM | MEM-101A |
| CD30 | Ki-1 | 105-120kD | TNFRSF | Bact, T and NK , Reed-Sternberg cells, anaplastic large cell lymphoma | CD153 receptor, lymph proliferation / apoptosis | |
| CD31 | PECAM-1 | 130-140kD | IgSF | mono, platelets, gran, endoth, lymph subset | CD38 receptor, adhesion | WM59 |
| CD32 | FcgammaRII | 40kD | IgSF | mono, gran, B, platelets | low affinity Fc receptor for aggregated Ig and immune complexes | |
| CD33 | p67, Siglec-3 | 67kD | IgSF, sialoadhesins | myeloid progenitors, mono, gran, DC, mast cells, Tact | adhesion | HIM3-4 |
| WM53 | ||||||
| CD34 | 105-120kD | Sialomucin, type I TM | hematopoietic precursors, capillary endoth, embryonic fibroblasts | stem cell marker, adhesion, CD62L receptor | ||
| CD35 | CR1 | 250kD | CCRSF | erythrocytes, B, mono, neutrophils, eosinophils, FDC, T subset | complement receptor 1, binds C3b and C4b, adhesion, phagocytosis | |
| CD36 | GPIV | 88kD | platelets, mono, mac, endoth, early erythrocytes | ECM receptor, adhesion, phagocytosis | mAb (please inquire) | |
| CD37 | 40-52kD | TM4SF | B, Tlow, granlow | signal transduction | ||
| CD38 | T10 | 45kD | variable levels on majority of hematopoietic cells, high expression on plasma cells, B and Tact | ecto-ADP-ribosyl cyclase, cell activation | HIT2 | |
| CD39 | 78kD | NK, mac, Langerhans cells, DC, Bact | B cell adhesion, protects activated cells from lysis, ecto-apyrase | |||
| CD40 | 48kD | TNFRSF | B, mono, mac, FDC, endoth, T subset | CD154 receptor, B differentiation / costimulation, isotype-switching, rescues B cells from apoptosis | 5C3 | |
| CD41 | gpIIb | 125/22kD | Integrin family | platelets, megakaryocytes | with CD61 forms GPIIb, binds fibrinogen, fibronectin, vWF, thrombospondin, platelet activation and aggregation | HIP2 |
| HIP8 | ||||||
| CD42a | GPIX | 22kD | LRRF | platelets, megakaryocytes | complex with CD42b, c and d, receptor for vWF and thrombin, platelet adhesion to subendothelial matrices | |
| CD42b | GPIba | 145kD | LRRF | platelets, megakaryocytes | complex with CD42a, c and d, binds to vWF and thrombin, platelet adhesion / activation | HIP1 |
| CD42c | GPIbb | 24kD | LRRF | platelets, megakaryocytes | complex with CD42a, b, d | |
| CD42d | GPV | 82kD | LRRF | platelets, megakaryocytes | complex with CD42a-c | |
| CD43 | Leukosialin, sialophorin | 115-135kD | Sialomucin, type I TM | leukocytes, except resting B, plateletslow | inhibition of T cell interaction, CD54R, adhesion | L10 |
| CD44 | H-CAM, Pgp-1 | 80-95kD | hyaladherin family | hematopoietic and non-hematopoietic cells, except platelets, hepatocytes, testis | binds hyaluronic acid, adhesion | IM7 |
| CD44R | CD44v | CD44 variants heterogeneous expression, constitutively on epith, mono, upregulated on activated leukocytes | adhesion, metastasis | |||
| CD45 | LCA, T200, B220 | 180-240kD | hematopoietic cells, multiple isoforms from alternative splicing | tyrosine phosphatase, enhanced TCR & BCR signals | HI30 | |
| RA3-6B2 | ||||||
| CD45RA | 205-220kD | B, T subset(naive), mono | exon A isoforms of CD45 | HI100 | ||
| JS-83 | ||||||
| CD45RB | 190-220kD | T subset, B, mono, mac, gran | exon B isoforms of CD45 | MEM-55 | ||
| CD45RO | 180kD | Tact, memory T, B subset, mono, mac, gran | isoform of CD45 lacking A, B, C exons | UCHL1 | ||
| CD46 | MCP | 56/66kD | CCRSF | nucleated cells | membrane cofactor protein, binds C3b & C4b allowing degradation by Factor I, measles virus receptor | |
| CD47 | IAP | 47-52kD | IgSF | hematopoietic cells, epith, endoth, fibroblasts, other tissues | leukocyte adhesion, migration, activation | |
| CD47R | New designation for CDw149, similar distribution as CD47 but dimmer | |||||
| CD48 | Blast-1 | 45kD | IgSF | broad, all leukocytes | cell adhesion | |
| CD49a | VLA-1 | 210kD | Integrin family | Tact, mono | integrin alpha1, adhesion, CD49a/CD29 binds collagen and laminin | |
| CD49b | VLA-2 | 165kD | Integrin family | B, mono, platelets, Tact, megakaryocytes | integrin alpha2, adhesion, CD49b / CD29 binds collagen and laminin | eBioY418 |
| CD49c | VLA-3 | 125kD | Integrin family | B and Tlow, most adhesive cell lines | integrin alpha3, adhesion, CD49c/CD29 binds laminin, fibronectin and collagen | mAb (please inquire) |
| CD49d | VLA-4 | 150kD | Integrin family | T, B, NK, thymocytes, mono, eosinophils, mast, DC | integrin alpha4, adhesion, CD49d/CD29 binds fibronectin, VCAM-1 & MAdCAM-1 | 9F10 |
| CD49e | VLA-5 | 135, 25kD | Integrin family | thymocytes, T, mono, platelets, early and Bact | integrin alpha5, adhesion, CD49e/CD29 binds fibronectin | |
| CD49f | VLA-6 | 125kD | Integrin family | memory T, thymocytes, mono, platelets, megakaryocytes, epith | integrin alpha6, adhesion, CD49f / CD29 binds laminin | |
| CD50 | ICAM-3 | 110-120kD | IgSF | hematopoietic, endoth, epidermal Langerhans cells | adhesion, costimulation | TP1/25.1 |
| CD51 | Vitronectin receptor | 125, 24kD | Integrin family | plateletslow, endoth, osteoblasts, melanomas | integrin alphav, adhesion, CD51 / CD61 binds vitronectin, vWF, fibrinogen and thrombospondin | 23C6 |
| CD52 | CAMPATH-1 | 21-28kD | thymocytes, T, B (not plasma cells), mono, mac | |||
| CD53 | 35-42kD | TM4SF | leukocytes, DC, osteoblasts, osteoclasts | signal transduction | ||
| CD54 | ICAM-1 | 90-110kD | IgSF | endoth, mono, lymph (high upon activation) | receptor for CD11a / CD18 (LFA-1), CD11b/CD18 (Mac-1) and rhinovirus | HA58 |
| CD55 | DAF | 60-70kD | GPI-linked | hematopoietic, endoth | binds C3b, complement regulation | 143-30 |
| CD56 | NCAM | 175-185kD | IgSF | NK, T subset, neurons, some large granular lymphocyte leukemias, myeloid leukemias | adhesion | MEM188 |
| CD57 | HNK-1, Leu-7 | 110kD | NK subset, T subset | TB01 | ||
| CD58 | LFA-3 | 55-70kD | IgSF | hematopoietic, non-hematopoietic cells | CD2 receptor, adhesion | |
| CD59 | Protectin, MAC- inhibitor | 19kD | GPI-linked | hematopoietic, non-hematopoietic cells | binds complement C8 and C9, blocks assembly of membrane attack complex | MEM-43 |
| CD60a | GD3 | CHO | T subset, platelets, thymic epith, astrocytes | costimulation | ||
| CD60b | 9-O-sialyl GD3 | CHO | T subset, Bact | |||
| CD60c | 7-O-sialyl GD3 | CHO | T subset | |||
| CD61 | GPIIIa | 105kD | Integrin family | platelets, megakaryocytes, mac, endoth | integrin beta3, adhesion, CD41/CD61 or CD51 / CD61 mediate adhesion to ECM | 23C6 |
| CD62E | E-selectin, ELAM-1 | 97,107-115kD | Selectin family | endoth | binds CD15s, cell rolling, metastasis | |
| CD62L | L-selectin, LECAM-1 | 74, 95kD | Selectin family | B, naïve and memory T, mono, gran, NK, thymocytes | CD34, GlyCAM, and MAdCAM-1 receptor, leukocyte homing, tethering, rolling | Dreg56 |
| CD62P | P-selectin, PADGEM | 140kD | Selectin family | activated platelets, endoth | CD162, CD15s receptor, adhesion, neutrophil rolling, platelet-neutrophil and platelet-mono interactions | AK-4 |
| CD63 | LIMP, LAMP-3 | 53kD | TM4SF | activated platelets, mono, mac | lysosomal membrane protein, moves to cell surface after activation | |
| CD64 | FcgammaRI | 72kD | IgSF | mono, mac, DC, Interferon or G-CSF activated gran | high affinity receptor for IgG, phagocytosis and ADCC | 10.1 |
| CD65 | gran, mono subset, myeloid leukemias | |||||
| CD65s | VIM2 | gran, mono, myeloid leukemias | phagocytosis | |||
| CD66a | BGP-1, NCA-160 | 160-180kD | IgSF, CEA family | neutrophils, epith | cell adhesion | |
| CD66b | CD67, CGM6 | 95-100kD | IgSF, CEA family | gran | cell adhesion, neutrophil activation | |
| CD66c | NCA | 90kD | IgSF, CEA family | neutrophils, colon carcinoma | cell adhesion | |
| CD66d | CGM1 | 35kD | IgSF, CEA family | neutrophils | ||
| CD66e | CEA | 180-200kD | IgSF, CEA family | colon epith, colon cancer | cell adhesion | |
| CD66f | PSG, Sp-1 | 54-72kD | IgSF, CEA family | pregnancy specific glycoprotein, placental syncytiotrophoblasts, fetal liver | immune regulation, protects fetus from maternal immune system | |
| CD68 | Macrosialin, gp110 | 110kD | Sialomucin | intracellularly in mono, mac, neutrophils, basophils, large lymph, mast cells, DC, myeloid progenitors, liver | eBioY1/82A | |
| CD69 | AIM | 28, 32kD | C-type lectin | Tact, B, NK and gran, thymocytes, platelets, Langerhans cells | signal transduction | FN50 |
| CD70 | Ki-24 | 50, 70, 90, 160kD | TNFSF | Bact and Tact | CD27 ligand, T and B cell costimulation | |
| CD71 | T9 | 95kD | proliferating cells, reticulocytes, erythroid precursors | transferrin receptor, iron uptake | T56/14 | |
| OKT9 | ||||||
| CD72 | Lyb-2 | 42kD | C-type lectin | B, FDC | CD5, CD100 receptor, B proliferation | |
| CD73 | 69kD | GPI-linked | B subset, T subset, FDC, epith | ecto-5’-nucleotidase, nucleoside uptake, T costimulation, lymph adhesion | ||
| CD74 | Ii, invariant chain | 33, 35, 41, 43kD | B, mac, mono, Langerhans cells, DC, Tact | MHC class II traffic and function | ||
| CD75 | CHO Sialoglycan family | B subset, epith | lactosamines | |||
| CD75s | CHO Sialoglycan family | B subset, T subset | alpha-2,6-sialylated lactosamines (previously CDw75 and CDw76) | |||
| CD77 | Gb3, Pk blood group | germinal center B, Burkitt’s lymphomashigh, follicular lymphomaslow | apoptosis | |||
| CD79a | Iga | 33, 45kD | IgSF | B | component of BCR, BCR surface expression and signal transduction | |
| CD79b | Igb | 37kD | IgSF | B | component of BCR, BCR surface expression and signal transduction | SN8 |
| CD80 | B7, B7-1, BB1 | 60kD | IgSF | Bact and Tact, mac, DC | binds to CD28, CD152, T costimulation | 2D10.4 |
| CD81 | TAPA-1 | 26kD | TM4SF | T, B, NK, thymocytes, DC, endoth, fibroblast, neuroblastomas, melanomas | complex with CD19 & CD21, signaling, T costimulation | |
| CD82 | R2 | 50-53kD | TM4SF | leukocytes | signal transduction | 53H5 |
| CD83 | HB15 | 43kD | IgSF | Bact and Tact, DC, Langerhans cells | HB15e | |
| CDw84 | 73kD | mono, platelets, B, T subset, mac subset | ||||
| CD85 | 110kD | IgSF, ILT/LIR family | DC, mono, B, NK, T subset | inhibition of NK, T cell cytolytic function | ||
| CD86 | B70, B7-2 | 80kD | IgSF | mono, DC, Bact and Tact | binds to CD28, CD152, T costimulation | IT2.2 |
| CD87 | UPA-R | 39-66kD | GPI-linked | gran, mono, NK, Tact, endoth, fibroblasts | urokinase plasminogen activator receptor, inflammatory cell invasion, metastasis | |
| CD88 | C5aR | 40kD | TM7SF | gran, mono, DC | C5a receptor, granulocyte activation | |
| CD89 | FcalphaR | 55-75kD | IgSF | mono, mac, gran, neutrophils, B subset, T subset | IgA receptor, phagocytosis, degranulation, respiratory burst | |
| CD90 | Thy-1 | 25-35kD | IgSF, GPI-linked | CD34+ hematopoietic subset, neurons | hematopoietic stem cell and neuron differentiation | |
| CD91 | 600kD | LDLR family | mono, mac, neurons, fibroblasts | receptor for alpha-2-macroglobulin | ||
| CD92 | 70kD | neutrophils, mono, platelets, endoth, fibroblasts | ||||
| CD93 | 120kD | neutrophils, mono, endoth | mAb (please inquire) | |||
| CD94 | KP43 | 43kD | C-type lectin | NK, T subset | complex with NKG2, inhibits NK function | DX22 |
| CD95 | Apo-1, Fas | 45kD | TNFRSF | lymph (high upon activation), mono, neutrophils | FasL (CD178) receptor, apoptosis | DX2 |
| EOS9.1 | ||||||
| CD96 | TACTILE | 160kD | IgSF | NK, Tact | adhesion of activated T and NK | |
| CD97 | 74, 80, 90kD | TM7SF | Bact and Tact, mono, gran | |||
| CD98 | 4F2 | 80, 40kD | T, B, NK, gran, all human cell lines | cellular activation | ||
| CD99 | MIC2, E2 | 32kD | leukocytes | T cell activation, adhesion | 3B2/TA8 | |
| CD99R | E2 | 32kD | T, NK, myeloid cells | isoform of CD99 | ||
| CD100 | 150kD | hematopoietic cells except immature bone marrow cells, RBC and platelets | cell adhesion, cellular activation | |||
| CD101 | V7, p126 | 120kD | IgSF | mono, gran, DC, Tact | T cell activation | |
| CD102 | ICAM-2 | 55-65kD | IgSF | lymph, mono, platelets, endoth | binds CD11a / CD18, costimulation | |
| CD103 | HML-1, alpha6, integrin alphaE | 150, 25kD | Integrin family | intraepithelial lymph, lymph subset, activated lymph | with integrin beta7, binds E-cadherin, lymph homing/retention | B-Ly7 |
| CD104 | beta4 integrin | 220kD | Integrin family | epith, Schwann cells, keratinocytes, some tumor cells | with integrin alpha6 (CD49f), cell adhesion, differentiation, metastasis | |
| CD105 | Endoglin | 95kD | homodimer | endoth, bone marrow subset, activated mac | cellular response to TGF-beta1 | SN6 |
| CD106 | VCAM-1 | 110kD | IgSF | activated endoth, FDC | VLA-4 (CD49d / CD29) receptor, leukocyte adhesion, migration, costimulation | STA |
| CD107a | LAMP-1 | 110kD | activated platelets, T, endoth, metastatic tumors | a lysosomal membrane protein | eBioH4A3 (H4A3) | |
| CD107b | LAMP-2 | 120kD | activated platelets, T, endoth, metastatic tumors | a lysosomal membrane protein | eBioH4B4 (H4B4) | |
| CD108 | 80kD | erythrocytes, lymphoblasts, resting lymphlow | ||||
| CD109 | 170kD | Tact and platelets, CD34+ subset, endoth | ||||
| CD110 | MPL, TPO-R | 82-84kD | CRSF | megakaryocytes, platelets, some CD34+ stem cellslow | thrombopoietin receptor, megakaryocyte progenitor cell growth / differentiation | |
| CD111 | PRR1, Nectin-1 | 64-72kD | IgSF | stem cell subset, mac, neutrophils | ||
| CD112 | PRR2, Nectin-2 | 64-72kD | IgSF | mono, neutrophils, CD34+ subset, megakaryocytes, endoth, epith | intercellular adhesion | |
| CD113 | PVRL3, Nectin3 | 83kD | IgSF | testis, placenta | adhesion molecule that interacts with afadin | |
| CD114 | G-CSFR | 95, 139kD | CRSF | myeloid progenitors, endoth | myeloid differentiation / proliferation | |
| CD115 | M-CSFR, c-fms | 150kD | IgSF, RTK family | mono, mac, monocytic progenitors | CSF-1R, monocytic differentiation / proliferation | 12-3A3-1B10 |
| CD116 | GM-CSFRalpha | 70-85kD | CRSF | mono, gran, DC, endoth | with common beta, myeloid differentiation / proliferation | 4H1 |
| CD117 | c-kit, SCFR | 145kD | IgSF, RTK family | hematopoietic progenitors, mast cells | SCF receptor, hematopoietic progenitor development / differentiation | YB5.B8 |
| CD118 | LIFR, gp190 | 190kD | Type I CRSF & secreted forms | epithelial cells in adult and embryo | membrane-bound involved in signal transduction, soluble form inhibits activity of LIF | |
| CD119 | IFNgammaR | 90-100kD | mac, mono, B, T, NK, neutrophils, endoth | IFN-gamma Ralpha, with IFN-gamma AF-1, host defense | ||
| CD120a | TNFR-I | 50-60kD | TNFRSF | hematopoietic, non-hematopoietic cells | receptor for both TNF-alpha and TNF-beta | |
| CD120b | TNFR-II | 75-85kD | TNFRSF | hematopoietic, non-hematopoietic cells | receptor for both TNF-alpha and TNF-beta | |
| CD121a | IL-1R type I | 80kD | IgSF | dimly expressed on many cells | binds IL-1alpha and IL-1beta, IL-1 signaling | |
| CD121b | IL-1R, type II | 60-70kD | IgSF | B, mac, mono, T subset | binds IL-1alpha and IL-1beta, negative signals | |
| CD122 | IL-2Rbeta | 75kD | CRSF | NK, T, B, mono | IL-2Rbeta and IL-15Rbeta, signal transduction | |
| CD123 | IL-3R | 70kD | CRSF | lymph subset, basophils, hematopoietic progenitors, mac, DC, megakaryocytes | IL-3Ralpha, with CDw131 | 6H6 |
| CD124 | IL-4R | 140kD | CRSF | lymphlow, mono, hematopoietic precursors, .broblast, epith | IL-4Ralpha, with CD132 or IL-13Ralpha, T cell growth / differentiation | X2/45-12 |
| CD125 | IL-5R | 60kD | CRSF | eosinophils, basophils | IL-5Ralpha, with CDw131 | |
| CD126 | IL-6R | 80kD | IgSF, CRSF | Bact and plasma cells, most leukocyteslow, fibroblasts | IL-6Ralpha, with CD130 | |
| CD127 | IL-7R | 65-75kD | CRSF | T, pro-B | IL-7Ralpha, with CD132, B and T cell development | eBioRDR5 |
| CD128 | see CD181 & CD182 | |||||
| CD130 | IL-6Rbeta, gp130 | 130kD | CRSF | Bact and plasma cells, most leukocyteslow, endoth | IL-6Rbeta, IL-6, IL-11, LIF, CNF signals | |
| CD131 | IL-3R common beta | 95-120kD | CRSF | mono, gran, early B | with alpha subunits of IL-3R, IL-5R, and GM-CSFR, signal transduction | 1C1 |
| CD132 | Common gamma | 64kD | CRSF | T, B, NK, mono, gran | subunit of IL-2R, IL-4R, IL-7R, IL-9R, and IL-15R, signal transduction | mAb (please inquire) |
| CD133 | AC133, prominin-like 1 | 120kD | TM5SF | hematopoietic stem cell subset, epith, endoth | ||
| CD134 | OX-40 | 48-50kD | TNFRSF | Tact | T cell activation, differentiation, apoptosis | ACT35 |
| CD135 | Flt3/Flk2 | 130-150kD | RTK family | myelomonocytic, primitive B progenitors | tyrosine kinase, binds FLT3 ligand, early lymph development | BV10A4H2 |
| CD136 | MSP-R, RON | 180kD | RTK family | epith, CNS, PNS, hematopoietic subset | migration, morphological change and proliferation of different target cells | |
| CD137 | 4-1BB | 30kD | TNFRSF | Tact | T costimulation | |
| CD138 | Syndecan-1 | 80-150kD | Syndecan family | plasma cells, pre-B, basolateral surface of epith, meurons | receptor for ECM, cell morphology | DL-101 |
| CD139 | 228kD | B, mono, gran, erythrocyteslow | ||||
| CD140a | PDGFRalpha | 180kD | RTK family | fibroblasts, smooth muscle & glial cells, chondrocytes | binds PDGF A and B | |
| CD140b | PDGFRbeta | 180kD | RTK family | fibroblasts, smooth muscle & glial cells, chondrocytes | binds PDGF B | |
| CD141 | Thrombomodulin | 100kD | C-type lectin | mono, neutrophils, endoth, smooth muscle cells | initiation of protein C anticoagulant signal | |
| CD142 | Tissue Factor | 45kD | mono, endoth, keratinocytes, epith | binds clotting factor VIIa, initiator of clotting | ||
| CD143 | ACE | 170kD | endoth, epith, neurons, fibroblasts, activated mac | angiotensin converting enzyme, angiotensin II & bradykinin metabolism | ||
| CD144 | VE-Cadherin, Cadherin-5 | 130kD | Cadherin family | endoth | adhesion, cell-cell interaction | 16B1 |
| CD145 | 110, 90kD | endoth, some stromal cells | ||||
| CD146 | MUC18, S-endo | 113-118kD | IgSF | endoth, melanomas, FDC, Tact | adhesion | |
| CD147 | Neurothelin, basoglin | IgSF | leukocytes, erythrocytes, platelets, endoth | adhesion | ||
| CD148 | HPTP-eta | 240-260kD | gran, mono, DC, T (high upon activation) | tyrosine phosphatase R Type III | ||
| CD150 | SLAM | 75-95kD | IgSF | T subset (high upon activation), B, DC, endoth | costimulation, proliferation, Ig production, measles virus receptor | A12 (7D4) |
| CD151 | PETA-3 | 32kD | endoth, megakaryocytes, platelets, epith | cell adhesion | mAb (please inquire) | |
| CD152 | CTLA-4 | 33kD | IgSF | Tact and B | CD80 and CD86 receptor, negative regulation of T cell costimulation | 14D3 |
| eBio20A | ||||||
| CD153 | CD30L | 40kD | TNFSF | neutrophils, B, Tact and mac | CD30 ligand, T costimulation | |
| CD154 | CD40L, gp39, TRAP | 32-39kD | TNFSF | Tact | CD40 ligand, B and DC costimulation | 24-31 |
| CD155 | PVR | 80-90kD | IgSF | mono, mac, CD34+ thymocytes | Polio virus receptor (PVR) | |
| CD156a | ADAM8 | 69kD | neutrophils, mono | leukocyte extravasation | ||
| CD156b | TACE / ADAM 17 | 100kD | broad | cleaves membrane proteins (TNF, TGFalpha) to generate soluble forms | ||
| CD156c | ADAM10 | 98kD | Peptidase M12B family | lymphoid organs, peripheral blood leukocyte, cartilage, chondrocytes and fetal liver | proteolytic cleavage of cell-surface molecules including Notch, TNF-alpha, APP and ephrin-A2 | polyclonal |
| CD157 | BST-1 | 42-45kD | gran, mono, B progenitors, endoth | ADP-ribosyl-cyclic ADP-ribose hydrolase activities, pre-B cell growth | eBioSY11B5 (SY11B5) | |
| CD158a | p58.1 | 50-58kD | IgSF, KIR family | NK subset, T subset | inhibition of NK cell cytolytic activity, MHC class-I specific NK receptor | |
| CD158b | p58.2 | 50-58kD | IgSF, KIR family | NK subset, T subset | inhibition of NK cell cytolytic activity, MHC class-I specific NK receptor | |
| CD159a | NKG2A | 43kD | T subset, NK | with CD94, NK cell receptor | ||
| CD159c | NKG2C | 40kD | Type II C-Type Lectin | NK | with MHC class I HLA-E molecules, forms heterodimer with CD94 | |
| CD160 | BY55 | 27kD | IgSF | NK subset, T subset | costimulation | |
| CD161 | NKR-P1A | 40kD | C-type lectin | T subset, NK | NK cell-mediated cytotoxicity | |
| CD162 | PSGL-1 | 120kD | Mucin family | mono, gran, most lymph | CD62P, CD62L ligand, adhesion, rolling | |
| CD162R | PEN-5 | CHO | NK subset | |||
| CD163 | 130kD | Scavenger receptor SF | mono, mac | eBioGHI/61 (GHI/61) | ||
| CD164 | MGC-24 | 80kD | epith, mono, lymphlow, bone marrow stromal cells, CD34+ erythroid progenitors | hematopoietic progenitor cell-stromal cell interaction | ||
| CD165 | AD2, gp37 | 42kD | lymph subset, mono, immature thymocytes, platelets | adhesion, thymocyte-thymic epith interaction | ||
| CD166 | ALCAM | 105kD | IgSF | neurons, mono, epith, fibroblasts, Tact | CD6 ligand, adhesion | |
| CD167a | DDR1 | 120kD | RTK family | epith, myoblasts | tyrosine kinase, adhesion to collagen | |
| CD168 | RHAMM | 84-88kD | mono, T subset, thymocyte subset, intracellularly in breast cancer cells | adhesion, tumor migration, metastasis | ||
| CD169 | sialoadhesin, Siglec-1 | 185kD | IgSF, sialoadhesins | tissue mac subset | adhesion, cell-cell and cell-matrix interactions, binds CD227 on breast cancer cells and CD43 on T cells | |
| CD170 | Siglec-5, CD33-like2 | 140kD | IgSF, sialoadhesins | Mac subset, neutrophils | adhesion | |
| CD171 | L1 | 200-210kD | IgSF | CNS, PNS, glial cells, mono, T subset, B, DC, several human tumor cells | kidney morphogenesis, lymph node architecture, T costimulation, neurohistogenesis, homotypic interaction, binds CD9, CD24, CD56, CD142, CD166, integrins | |
| CD172a | SIRPgamma | 110kD | mono, T subset, stem cells | adhesion, complex with CD47 | ||
| CD172b | SIRPbeta, SIRB1 | 50kD | IgSF | mono and DC | negative regulation of RTK-coupled signaling | |
| CD172g | SIRPgamma, SIRPB2 | 45-50kD | IgSF, ASV | mRNA: liver and at lower levels in many tissues | binds CD47 | |
| CD173 | Blood group H type 2 | CHO | erythrocytes, stem cell subset, platelets | |||
| CD174 | Lewis Y | CHO | stem cells subset, epith | |||
| CD175 | Tn | CHO | stem cells subset | |||
| CD175s | Sialyl-Tn | CHO | erythroblasts | |||
| CD176 | Thomson Friedrenreich Ag | CHO | stem cell subset | |||
| CD177 | NB1 | 56-62kD | neutrophil subset | |||
| CD178 | FasL, CD95L | 38-42kD | TNFSF | Tact, testis | CD95 ligand, apoptosis, immune privilege, soluble form in serum | NOK-1 |
| CD179a | V pre B | 16-18kD | IgSF | Pro- and Pre-B | B cell differentiation / signaling, with IgM | |
| CD179b | Lambda 5 | 22kD | IgSF | Pro- and Pre-B | B cell differentiation / signaling, with IgM | |
| CD180 | RP-105 | 95-105kD | LRRF, TLR family | B subset, mono, DC | B cell activation, LPS signaling, with MD-1 | MHR73-11 |
| CD181 | CXCR1, IL-8RA | 39kD | GPCR1 family | neutrophils, basophils, NK, T subset, mono | binding of IL-8 induces chemotaxis of neutrophils | mAb (please inquire) |
| CD182 | CXCR2, IL-8RB | 40kD | GPCR1 family | neutrophils, basophils, NK, T subset, mono | binding of IL-8 induces chemotaxis of neutrophils | mAb (please inquire) |
| CD183 | CXCR3 | 40kD | TM7SF | eosinophils, Tact and NK, GM-CSF activated CD34+ progenitors | IP-10 , Mig and I-TAC receptor, T cell recruitment to inflammatory sites, enhancement of Th1 response | |
| CD184 | CXCR4, fusin | 45kD | TM7SF | B, DC, T subset, mono, endoth | SDF-1 receptor, X4 HIV-1 coreceptor | 12G5 |
| CD185 | CXCR5, BLR1 | 45kD | GPCR1 family | mature B and Burkitt Lymphoma cells | with chemokine BLC, possible regulatory function in Burkitt Lymphomagenesis and/or B differentiation, activation of mature B | |
| CD186 | CXCR6, BONZO | 40kD | GPCR1 family | Tact | receptor for CXCL16 and coreceptor for SIV, strains of HIV-2 and m-tropic HIV-1 | polyclonal |
| CD191 | CCR1, MIP-1alphaR, RANTES-R | 39kD | GPCR1 family | T, mono, stem cell subset | binds C-C type chemokines and transduces signal by increasing intracellular calcium ion levels | |
| CD192 | CCR2, MCP-1-R | 40kD | GPCR1 family | activated NK and mononuclear phagocytes, T subset, B, endoth | binds MCP-1, MCP-3 & MCP-4, alternative coreceptor with CD4 for HIV-1 infection | |
| CD193 | CCR3, CKR3 | 45kD | GPCR1 family | eosinophils, lower expression in neutrophils and mono, T subset | binds eotaxin, eotaxin-3, MCP-3, MCP-4, RANTES & MIP-1delta, alternative coreceptor with CD4 for HIV-1 infectiongg | mAb (please inquire) |
| CD195 | CCR5 | 45kD | mono, T subset | MIP-1alpha, MIP-1beta and RANTES receptor, R5 HIV-1 coreceptor | eBioT21/8 (T21/8) | |
| R22/7 | ||||||
| V14/2 | ||||||
| polyclonal | ||||||
| CD196 | CCR6, LARC receptor, DRY6 | 45kD | GPCR1 family | T subset, B, DC subset | binds MIP-3alpha/LARC | |
| CD197 | CCR7 | 45kD | T subset, DC Subset | 6Ckine and MIP-2beta receptor | CCR7.6B3 | |
| CD198 | CCR8, GPRCY6, TER1 | 50kD | GPCR1 family | T, high expression in Th2, NK, mono | allergic inflammation, alternative coreceptor with CD4 for HIV-1 infection | polyclonal |
| CD199 | CCR9, GPR-9-6 | 43kD | GPCR1 family | subset of memory T, lamina propria mononuclear cells | binds SCYA25/TECK, alternative coreceptor with CD4 for HIV-1 infection | |
| CD200 | OX-2 | 45-50kD | thymocytes, endoth, B, Tact | inhibition of immune response | ||
| CD201 | EPC-R | 50kD | endoth subset | activated protein C receptor | ||
| CD202b | Tie2, Tek | 150kD | RTK family | stem cells, endoth | angiopoietin-1 receptor | |
| CD203c | NPP3 / PDNP3, ENpp1, PD-1b | 130-150kD | type II TM | basophils, mast cells, glioma cells, megakaryocytes | ectoenzyme, binding to and clearance of extracellular nucleotides | |
| CD204 | Macrophage scavenger-R | 220kD | mac | endocytosis of macromolecules | ||
| CD205 | DEC-205 | 205kD | DC, thymic epith | DC, thymic epith | MG38 | |
| CD206 | macrophage mannose-R | 180kD | DC subset, mac, mono | phagocytosis and pinocytosis of mannose containing molecules | ||
| CD207 | Langerin | 40kD | Langerhans cells | endocytic receptor | ||
| CD208 | DC-LAMP | 70-90kD | DCact, interdigitating DC | |||
| CD209 | DC-SIGN | 44kD | DC subset | ICAM-3 receptor, HIV-1 binding protein | eB-h209 | |
| polyclonal | ||||||
| CD210 | IL-10-R | 90-110kD | T, B, NK, mono, mac | IL-10 receptor, signal transduction | ||
| CD212 | IL-12-R beta1 | 100kD | Tact and NK | binds IL-12 with high affinity, associates with IL-12 receptor beta2 | ||
| CD213a1 | IL-13-R alpha1 | 65kD | B, mono, fibroblasts, endoth | binds IL-13 with low affinity, with CD124 | ||
| CD213a2 | IL-13-R alpha2 | 65kD | B, mono | binds IL-13 with high affinity | ||
| CD217 | IL-17-R | 120kD | broad | IL-17 receptor | ||
| CD218a | IL-18Ralpha, IL-1Rrp | 70kD | IL-1R family | T, NK, DCs | binds IL-18, activation of NF-kappaB | H44 |
| CD218b | IL-18Rbeta, IL18RAP | 70kD | IL-1R family | T, NK and DCs | heterodimeric receptor with IL-18Ralpha to enhance IL-18 binding | |
| CD220 | Insulin-R | 140, 70kD | broad | insulin receptor | ||
| CD221 | IGF-1 R | 140, 70kD | broad | binds IGF with high affinity, signaling, cell proliferation/ differentiation | ||
| CD222 | IGF-II R, mannose-6 phosphate-R | 250kD | Type I TM | broad, 90-95% intracellular | adhesion, tumor growth, a receptor for TGFbeta-LAP, plasminogen, proliferin, truncated form (220kD) found in serum | |
| CD223 | LAG-3 | 70kD | IgSF | Tact and NK | an MHC class II ligand | mAb (please inquire) |
| CD224 | GGT | 27, 68kD | leukocytes, stem cells | |||
| CD225 | Leu-13 | 17kD | broad | |||
| CD226 | DNAM-1, PTA-1, TLiSA1 | 65kD | IgSF | T, NK, mono, platelets, activated HUVEC | activation of cell-mediated cytotoxicity, soluble form (50kD) found in normal serum | |
| CD227 | MUC1, EMA | 300kD | Mucin family, type I TM | epith, stem cell subset, FDC, mono, B subset, some myelomas | adhesion, signaling, binds CD169, CD54, & selectins | mAb (please inquire) |
| CD228 | Melanotransferrin | 80-95kD | stem cells, melanomas | |||
| CD229 | Ly-9 | 95, 110kD | IgSF | T, B | adhesion | |
| CD230 | Prion protein | 35kD | broad | |||
| CD231 | TALLA-1, A15 | 30-45kD | TM4SF | T leukemias, neuroblastomas, brain neurons | marker for T cell acute lymphoblastic leukemia | |
| CD232 | VESP-R | 200kD | broad | |||
| CD233 | Band 3, SLC4A1 | 90kD | Anion exchanger family | erythrocytes | anion exchanger pump, transport of CO2, linking red cell membrane to cytoskeleton | |
| CD234 | Duffy, DARC | 35-45kD | erythrocytes | Duffy antigen chemokine receptor | ||
| CD235a | Glycophorin A | 36kD | erythrocytes | HIR2 (also GA-R2) | ||
| CD235ab | Glycophorin A/B | 20kD | erythrocytes | mAb (please inquire) | ||
| CD235b | Glycophorin B | 20kD | erythrocytes | |||
| CD236 | Glycophorin C/D | 32, 23kD | erythrocytes, stem cell subset | |||
| CD236R | Glycophorin C | 32kD | erythrocytes, stem cell subset | |||
| CD238 | Kell | 93kD | erythrocytes, stem cell subset | |||
| CD239 | B-CAM | 78-85kD | erythrocytes, stem cell subset | |||
| CD240CE | Rh30CE | 30-32kD | erythrocytes | |||
| CD240D | Rh30D | 30-32kD | TM12SF | erythrocytes | ||
| CD241 | RhAg, Rh50 | 50kD | TM12SF | erythrocytes | complex with CD47, LW, glycophorin B | |
| CD242 | ICAM-4 | 42kD | IgSF | erythrocytes | adhesion, Landsteiner-Wiener blood group | |
| CD243 | MDR-1, p170, P-gp | 180kD | stem cells, small intestine, kidneystem cells, small intestine, kidney | ion pump | ||
| CD244 | 2B4 | 70kD | type II TM | T subset, mono, basophils, NK | NK activation, CD48 ligand | eBioDM244 |
| eBioC1.7 (C1.7) | ||||||
| CD245 | p220/240 | 220-240kD | T subset | |||
| CD246 | ALK, Ki-1 | 80kD | anaplastic T cell leukemias, small intestine, testis, brain, not on normal lymph | brain development, implicated in ALK lymphomas | ||
| CD247 | TCRz | 16kD | RTK family | T, NK | TCR complex subunit, coupling of antigen recognition to signaling | |
| CD248 | TEM1, Endosialin | 175kD | C-Type Lectin | endothelial tissue, stromal fibroblasts | tumor progression and angiogenesis | |
| CD249 | Aminopeptidase A | 160kD | Peptidase M1 family | epith, endoth | renin-angiotensin system | |
| CD252 | OX-40Ligand, gp34 | 34kD | TNFSF | Bact, cardiac myocytes | T costimulation | |
| CD253 | TRAIL, Apo-2L, TL2, TNFSF10 | TNFSF | Tact, many tissues | death | RIK-2 | |
| polyclonal | ||||||
| CD254 | TRANCE, RANKL, OPGL | 35kD | TNFSF | lymph node & BM stroma Tact | binds OPG and RANK, osteoclast differentiation, enhances DC to stimulate naïve-T proliferation | MIH23 |
| MIH24 | ||||||
| CD256 | APRIL, TALL-2 | 16kD | TNFSF | mono, mac | binds TACI & BCMA, B proliferation | polyclonal |
| CD257 | BLyS, BAFF, TALL-1 | TNFSF | monoact, soluble form | B cell growth factor & costimulator of Ig production | 1D6 | |
| polyclonal | ||||||
| CD258 | LIGHT, HVEM-L | 28kD | TNFSF | Tact, immature DC | binds LTBR, T proliferation, receptor for HVEM | |
| CD261 | TRAIL-R1, DR4 | 57kD | TNFRSF | Tact, peripheral blood leukocytes | contains death domain, apoptosis via FADD & caspase-8 | DJR1 |
| polyclonal | ||||||
| CD262 | TRAIL-R2, DR5 | 60kD | TNFRSF | widely expressed, peripheral blood lymphocytes | contains death domain, apoptosis via FADD and caspase-8 | DJR2-4 |
| DJR2-2 | ||||||
| 2A7 | ||||||
| polyclonal | ||||||
| CD263 | TRAIL-R3, DcR1, LIT | 65kD | TNFRSF | peripheral blood lymphocytes | receptor for TRAIL but lacks death domain | DJR3 |
| polyclonal | ||||||
| CD265 | RANK, TRANCE-R, ODFR | 97kD | TNFRSF | broad expression | binds TRANCE, osteoclastogenesis, T-DC interactions | 9A725 |
| CD266 | TWEAK-R, FGF-inducible 14 | 14kD | TNFRSF | heart, placenta and kidney, HUVEC | TWEAK receptor, cell-matrix interactions and endoth growth and migration | ITEM-1 |
| ITEM-2 | ||||||
| ITEM-4 | ||||||
| CD267 | TACI, TNFR SF13B | B, Tact | binds BAFF & APRIL | 11H3 | ||
| polyclonal | ||||||
| CD268 | BAFFR, TR13C | 25kD | TNFRSF | B | binds BLyS, mature B survival | 8A7 |
| polyclonal | ||||||
| CD269 | BCMA, TNFRSF13B | 20kD | TNFRSF | mature B (membrane and perinuclear) | APRIL & BAFF receptor, B survival & proliferation | |
| CD271 | NGFR, p75 (NTR) | 45kD | TNFRSF | neurons (schwann cells, growing neurites), BM mesencymal cells | NGF, BDNF, NT-3, & NT-4 receptor, tumor suppressor, cell survival and death | |
| CD272 | BTLA | 33kD | IgSF | Tact, B , remains on Th1 | HVEM receptor, inhibitory response | MIH26 |
| CD273 | B7DC, PD-L2, PDCD1L2 | 25kD | IgSF | DC subset, mono, mac | PD-1 receptor, costimulation or suppression of T proliferation | MIH18 |
| CD274 | B7-H1, PD-L1 | 33kD | IgSF | leukocytes, broad | PD-1 receptor, costimulation of lymphocytes | MIH1 |
| CD275 | B7-H2, ICOSL, B7-RP1, GL50 | 60kD | B7 Family | B, DC, mono | costimulation, cytokine production | eBioMIH39 |
| MIH12 | ||||||
| CD276 | B7-H3 | 40-45kD | B7 Family, ASV | in vitro cultured DC and mono, Tact, mammary tissue | costimulation, T activation | M3.2D7 |
| CD277 | BT3.1, butyrophilin SF3 A1, BTF5 | 56kD | B7/BT family, ASV | T, B, NK, mono, DC, endoth, CD34+ cells, tumor cell lines | T activation | eBioBT3.1 (20.1, BT3.1) |
| CD278 | ICOS, AILIM | 55-60kD | CD28 family | Tact, Th2 | binds ICOS-L, T costimulation | ISA-3 |
| CD279 | PD1, SLEB2 | 55kD | Tact and Bact | B7-H1 & B7-DC receptor, autoimmune disease and peripheral tolerance | J116 | |
| MIH4 | ||||||
| CD280 | ENDO180, UPARAP | 180kD | C-type lectin SF | chondrocytes, fibroblasts, endothelial, mac | mannose receptor, collagen matrix remodeling and endocytic recycling | |
| CD281 | TLR1 | 90kD | TLR family | low levels in PBMC, mono and possibly DC | innate immunity, with TLR2 | GD2.F4 |
| CD282 | TLR2 | 90kD | TLR family | mono, neutrophil, upregulated in mac | binds dsRNA, response to bacterial lipoproteins, innate immunity | TL2.1 |
| TL2.3 | ||||||
| T2.5 | ||||||
| polyclonal | ||||||
| CD283 | TLR3 | 100kD | TLR family, ASV | derived moDC (may be intracellular) | binds dsRNA, innate immunity | TLR3.7 |
| CD284 | TLR4 | 100kD | TLR family, ASV | PBMC (weak in mono, immature DC & neutro) | binds LPS, innate immunity | HTA125 |
| polyclonal | ||||||
| CD289 | TLR9 | 120kD | TLR family | pDC (intracellular) | binds CpG-DNA, innate immunity | eB72-1665 |
| CD292 | BMPR1A, ALK3 | 57kD | Type I | bone progenitor | BMP 2 & 4 receptor, bone development | |
| CD293 | BMPR1B, ALK6 | 57kD | Type I, ASV | bone progenitor | BMP receptor, bone development | |
| CD294 | CRTH2. GPR44 | 55-70kD | GPCR-7TM | Th2, eosinophils, basophils | binds prostaglandin D2, stimulatory effects on Th2, allergic inflammation | |
| CD295 | LeptinR, LEPR | 132kD | Type I cytokine-like receptor | broad | adipose metabolism, immune dysfunction in obesity | |
| CD296 | ART1, RT6, ART2 | 37kD | ADP- ribosyltransferase | heart and skeletal muscle, peripheral T, NK subset | modifies integrins during differentiation, ADP ribosylation of target proteins | |
| CD297 | ART4, dombrock blood group | 38kD | ADP- ribosyltransferase | erythroid, monoact | ADP ribosylation of target proteins | |
| CD298 | Na+/K+-ATPase beta3 subunit | 52kD | broad | transport sodium & potassium ions across membrane | ||
| CD299 | DC-SIGN-related, LSIGN, DC-SIGN2 | 45kD | Type II, similar to CD209, ASV | endothelial subset | binds ICAM3, HIV-1 gp120, coreceptor with DC-SIGN, HIV infection | |
| CD300a | CMRF35H, IRC1, IRp60 | 60kD | IgSF, ASV | NK, mono, neutrophils, T and B subset and lymphocytic cell lines, AML | unknown | |
| CD300c | CMRF35A, LIR | IgSF | mono, neutrophils, monocytic cell lines, B & T subsets | unknown | ||
| CD300e | CMRF35L | IgSF CMRF family | unknown | |||
| CD301 | MGL, HML | 38kD | C type lectin SF, ASV | immature DC | binds Tn antigen, uptake of glycosylated antigens | |
| CD302 | DCL1, BIMLEC | 19-28kD | Type I TM C-type lectin receptor | some myeloid and Hodgkin’s cell lines | a fusion protein in Hodgkin’s lymphoma with DEC-205 | |
| CD303 | BDCA2, HECL | 38kD | C-type lectin SF ASV | plasmacytoid dendritic cells | inhibit IFN-alpha production | |
| CD304 | BDCA4, neuropilin 1 | 130kD | semaphorin family | neurons, CD4+/CD25+ Treg, DC, endothelial and tumor cells | interacts with VEGF165 & semaphorins, co-receptor with plexin, axonal guidance, angiogenesis, cell survival, migration | |
| CD305 | LAIR1 | 32-40kD | IgSF, ASV | NK, B, T, mono | inhibitory receptor on NK and T cells | |
| CD306 | LAIR2 | IgSF, ASV | unknown | soluble, mucosal tolerance | ||
| CD307 | IRTA2 | 55-105kD | IgSF (Fc receptor), ASV | B subset, B lymphoma | B cell development, translocation in some lymphomas | |
| CD309 | VEGFR2, KDR | 230kD | Type III TM tyr kinase | endothelial, angiogenic precursor cells, hemangioblast | binds VEGF, regulates adhesion and cell signaling | |
| CD312 | EMR2 | 90kD | EGFR-7TM ASV | mono, mac, moDC, granslow | cell adhesion and migration for phagocytosis | |
| CD314 | NKG2D, KLR | 42kD | Type II lectin-like receptor | NK, CD8+ activated, NK1.1+ T, some myeloid cells | binds MHC class I, MICA, MICB, Rae1 & ULBP4, activates cytolysis and cytokine production, costimulation | 1D11 |
| 5C6 | ||||||
| CD315 | CD9P1, SMAP6, FPRP, PTGFRN | 135kD | IgSF | B subset, monoact | with CD81 and CD9 | |
| CD316 | EWI2, PGRL, CD81P3, KASP | 63-75kD | IgSF8 | B, T cells, low on NK cells | with CD81 & CD9; involved in cell migration | |
| CD317 | BST2, HM1.24 | 30-36kD | Type II | B, T, NK, mono, DC, fibroblast cell line, myeloma | pre-B cell growth, overexpressed in multiple myeloma | |
| CD318 | CDCP1, SIMA135 | 135kD | Type I, ASV | HSC (subset of CD34+), tumors | cell adhesion with ECM | |
| CD319 | CRACC, SLAMF7 | 66kD | Ig TM | T, B and DC subset, NK, upregulated in DC | regulate T and NK cells | |
| CD320 | 8D6A, 8D6 | 30kD | LDL receptor | follicular DC, germinal centers | B proliferation, tumor formation | |
| CD321 | JAM1, F11 receptor | 35kD | IgSF, Type I, ASV | platelet receptor, epithelia and endothelial, platelets | tight junctions | |
| CD322 | JAM2, VE-JAM | 43kD | IgSF | HEV, other endoth | cell adhesion, lymphocyte homing to secondary lymphoid organs | |
| CD324 | E-Cadherin, Uvomorulin | 120kD | cadherin SF | non-neural epith | cell adhesion, homotypic interaction & binds alphaE/beta7 | |
| CD325 | N-Cadherin, NCAD | 140kD | cadherin SF | brain, skeletal and cardiac muscle | cell adhesion, neuronal recognition | |
| CD326 | Ep-CAM, Ly74 | 35-40kD | most epith cell membranes | growth factor receptor? | ||
| CD327 | SIGLEC6 | IgSF | placenta, spleen, B . sialic-acid dependent | adhesion, membrane- bound & secreted forms | ||
| CD328 | SIGLEC7, AIRM-1 | 75kD | IgSF | resting and activated NK, placenta, liver, spleen, lower in gran & mono | sialic-acid dependent adhesion, inhibit NK activation, hemopoiesis | |
| CD329 | SIGLEC9 | IgSF | neutrophils and mono | sialic-acid dependent adhesion molecule | ||
| CD331 | FGFR1, Fms-like tyrosine kinase-2, KAL2, N-SAM | 30kD | TM tyr kinase | fibroblasts, epithelial | binds FGF, high affinity receptor for fibroblast growth factors | |
| CD332 | FGFR2, BEK, KGFR | 115-135kD | TM RTK family | fibroblasts, epithelial | binds FGF, high affinity receptor for fibroblast growth factors | |
| CD333 | FGFR3, ACH, CEK2 | 115kD | TM RTK family | fibroblasts, epithelial | binds FGF, high affinity receptor for fibroblast growth factors | |
| CD334 | FGFR4, JTK2, TKF | 110kD | TM RTK family | fibroblasts, epithelial | binds FGF, high affinity receptor for fibroblast growth factors | |
| CD335 | NKp46, Ly-94 homolog | 46kD | IgSF | NK | activates NK cells upon non-MHC ligand binding | |
| CD336 | NKp44, Ly-95 homolog | 44kD | IgSF | NK | activates NK cells upon non-MHC ligand binding | |
| CD337 | NKp30, Ly117 | 30kD | IgSF | NK | activates NK cells upon non-MHC ligand binding | |
| CD338 | ABCG2, BCRP, Bcrp1, MXR | 73kD | GPCR 7TM | stem cell subset (side population) | multi-drug resistance transporter | 5D3 |
| CD339 | Jagged-1, JAG1, JAGL1, hJ1 | 135kD | EGF TM | stromal cells, epithelial, AML | binds Notch, hematopoiesis |
| Antigen Name | Other Names | MW | Structure | Distribution | Function | eBioscience Clone |
|---|---|---|---|---|---|---|
| 4-1BB Ligand | CD137L | TNFSF | Bact, DC, carcinoma cell lines | T costimulation | ||
| AID | RNA-editing deaminase family | Bact, Germinal Center B | Activation-Induced Deaminase, Ig class switch recombination | hAID | ||
| AITR | TNFRSF18, GITR | Treg, Tact | costimulation | eBioAITR | ||
| AITRL | TNFSF18, TL6, GITRL | APC | eBioAITR-L | |||
| B7 family | see CD273-276 | |||||
| B7-H4 | B7-S1, B7x | B7 family | may interact with BTLA (?), inhibition | H74 | ||
| BAMBI | TGFBR | 29kD | TGFBR | carcinoma cell | pseudoreceptor for TGF-beta (short cytoplasmic domain), growth inhibition | 4.00E+08 |
| BCMA | see CD269 | |||||
| BLyS | see CD257 | |||||
| BR3 | see CD268 | |||||
| BTLA | see CD272 | |||||
| CCR7 | see CD197 | |||||
| c-Met | HGFR/SFR | 190kD | heterodimer, PTK | epith, hematopoietic progenitors, early thymocytes | tumor growth / metastasis, Hepatocyte Growth Factor / Scatter Factor receptor, T development, hematopoiesis | eBioclone 97 |
| CMKLR1 | chemokine-like receptor 1 | 42kD | GPCR 7TM, chemokine receptor | pDC (CD123+), in vitro derived moDC | binds chemerin, pDC recruitment, bone development | BZ332 |
| DcR3 | TR6, TNFRSF6B | Soluble | tumors | Fas decoy receptor, tumor evasion | 37A565 | |
| polyclonal | ||||||
| DEC-205 | see CD205 | |||||
| DR3 | TRAMP, Apo-3, WSL-1, LARD, TR3 | TNFRSF | Tact, leukocytes | lymphocyte homeostasis | JD3 | |
| polyclonal | ||||||
| DR6 | TR7 | TNFRSF | death, Th2 response | polyclonal | ||
| Fc epsilonRI alpha | high-affinity IgE receptor | tetramer complex | mast cells, basophils | triggers IgE-mediated allergic reactions | AER-37 (CRA1) | |
| Foxp3 | SCURFIN | 50kD | Fox family forkhead | T subsets (CD4+/CD25+ subset and CD8+ subset) | transcription factor, upregulated in T regs | PCH101 |
| 236A/E7 | ||||||
| eBio7979 | ||||||
| 150D/E4 | ||||||
| Granzyme B | Granzyme-2, CTLA-1 | 30kD | Peptidase S1 family | Cytotoxic T, NK | target cell apoptotic lysis, cell-mediated immune responses | eBioGrB |
| HLA-ABC | 45, 11-12kD | nucleated cells | cell-mediated immune response & tumor surveillance | W6/32 | ||
| HLA-DR | APC, Tact | presentation of peptides to CD4+ T lymphocytes | LN3 | |||
| HVEM | TNFRSF14, TR2 | 60kD | TNFRSF | broad expression | receptor for LIGHT, LT-alpha, BTLA, Herpes Simplex Virus, lymphocyte activation | eBioHVEM-122 |
| ICOS | see CD278 | |||||
| ICOSL | see CD275 | |||||
| IL-15R alpha | monoact | binds to IL-15, w/ IL-2RB and common gamma, IL-15 trans-presentation | mAb (please inquire) | |||
| Integrin beta5 | 100kD | carcinoma cell lines, fibroblast lines | w/ alphav subunit, vitronectin receptor | KN52 | ||
| MD-2 | 30KD | w/ TLR4 distribution and LPS recognition | 9B4 | |||
| MICA/MICB | 70kD | MHC Class I-related proteins | intestinal epith, some tumors | unregulated on epith after shock, NKG2D receptors | 6D4 | |
| Nanog | 34kD | ES cells | transcription factor, self renewal of ES cells | hNanog.1 | ||
| hNanog.2 | ||||||
| NKG2D | see CD314 | |||||
| NOD2 | CARD-15, IBD1 | monocytes, intracellular | 2D9 | |||
| Notch-1 | Lin-12, Tan 1 | developing embryo, variety of adult tissues | cell-cell interaction, cell fate determination | mN1A | ||
| OPG | TRAIL-R5, TR1, TNFRSF11B | binds TRAIL? | bone resorption | |||
| OX-40 | see CD134 | |||||
| OX-40 Ligand | see CD252 | |||||
| p38 | 38kD | SAP/MAP kinase | NK, CD8+ T subset, upregulated on CD8+T | role in cytolytic activity | eBioC1.7 (C1.7) | |
| PD-1 | see CD279 | |||||
| PD-L1 | see CD274 | |||||
| PD-L2 | see CD273 | |||||
| Perforin | 70-75kD | CTL, NK | cytolytic protein | eBioBOR21 | ||
| dG9 | ||||||
| RP105 | see CD180 | |||||
| RANK | see CD265 | |||||
| RANKL | see CD254 | |||||
| SAP | SLAM-associated protein | 14kD | adaptor protein | T, NK | negatively regulates SLAM- family receptors | mAb (please inquire) |
| SLP-76 | 76kD | T, Blow | T cell receptor mediated signaling | HS76 | ||
| SSEA-1 | stage-specific embryonic antigen-1 | ES cells, embryonic carcinomas, germ cells | down regulated by differentiation | eBioMC-631 (MC-631) | ||
| SSEA-3 | stage-specific embryonic antigen-3 | eBioMC-813-70 (MC-813-70) | ||||
| SSEA-4 | stage-specific embryonic antigen-4 | eBioMC-813-70 (MC-813-70) | ||||
| Stro-1 | BM stroma, erythroid progenitors | surface marker for immature mesenchymal cells | eBioStro-1 | |||
| TACI | see CD267 | |||||
| T-bet | Th1 cells | transcription factor, T development / differentiation | mAb (please inquire) | |||
| TCL1 | B cell tumors, lymphoid lineages in a developmentally controlled manner, pDC | intracellular, lymphoid proto-oncogene | eBio1-21 (1-21) | |||
| TCR alpha beta | peripheral T subset | antigen recognition | IP26 | |||
| TCR gamma delta | T subset | antigen recognition | B1.1 | |||
| TLR1 - TLR4 | see CD281 - CD284 | |||||
| TLR5 | TIL3 | TLR family | mRNA: leukocytes, prostate, ovary, liver, lung | interacts w/ microbial lipoproteins, NF-kappaB, responds to Salmonella | ||
| TLR6 | TLR family | mRNA: leukocytes, ovary, lung | interacts w/ microbial lipoproteins, protein sequence similar to hTLR1; regulates TLR2 response | hPer6 | ||
| TLR7 | TLR family | mRNA: spleen, placenta, lung; upregulated on mac | polyclonal | |||
| TLR8 | TLR family | mRNA: leukocytes, lung | polyclonal | |||
| TLR9 | see CD289 | |||||
| TLR10 | TLR family | mRNA: lymphoid tissues | most closely related to TLR1 and TLR6 | |||
| TNFRI | see CD120a | |||||
| TRAIL | see CD253 | |||||
| TSLPR | 50kD | heterodimer with IL-7Ralpha/CD127 | monocytes, DC, B | binds TSLP (Thymic Stromal Lymphopoietin) to activate DC | eBio1A6 (1A6) | |
| TWEAK | TNFSF12, APO3L | TNFSF | activated mono | death | CARL-1 | |
| CARL-2 | ||||||
| TWEAK Receptor | see CD266 | |||||
| ULBPs | MHC class I-related protiens, GPI-linked | tumors | NKG2D receptors, NK activation | family of ULBP-1-6 (please inquire) | ||
| ZAP-70 | TCRζ-associated kinase | 70kD | Syk family | Intracellular T, NK | TCR signaling & development | 1E7.2 |
